Jha said there is “no viable alternative path” right now than to have the U.S. government take the lead in securing COVID-19 vaccines and treatments, rather than allowing the commercial market deal with procurement as with other medical treatments. He cited the global mismatch between supply and demand.
“We have to have the US government still playing an active role,” he said. “That role will change over time. But right now that’s still critical.”
What mismatch? There's plenty of supply and a lack of people lining up to get stabbed in the arm.
“We have to have the US government still playing an active role,” he said. “That role will change over time. But right now that’s still critical.”
The AP Interview: US 'vulnerable' to COVID without new shots
The new White House COVID-19 coordinator is issuing a dire warning. He says in an Associated Press interview that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn’t swiftly approve new funding for more vaccines and treatments.
apnews.com
What mismatch? There's plenty of supply and a lack of people lining up to get stabbed in the arm.